1Termrungruanglert W, Tresukosol D, Vasuratna A,et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery insquamous cell carcinoma of cervix stage IB2[J]. Gynaecol Oncol, 2005,1997(2) : 576-581. 被引量：1
2Vrdoljak E, Harem W. Current state of the art of concomitant chemoradiation In cervical carcinomas. Eur[J]. Gynaecol Oncol, 2003,24(6) : 475-479. 被引量：1
4Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally adwanced Stage I B- II B cervical cancerafter ne o adjuvant chemotherapy and radical hysterectomy[J]. Gynecol Oncol,2006,82(1) :88-93. 被引量：1
二级参考文献18
1Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol,2001,20:179-188. 被引量：1
2Timotheadou E, Gore ME. Neoadjuvant chemotherapy for locally advanced cervical cance. Eur J Cancer, 2003,39 : 2419 -2421. 被引量：1
3Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage Ⅰ b - Ⅱb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001,82:88-93. 被引量：1
4Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol,2001,83 :263-267. 被引量：1
5Tabata T, Takeshima N, Nishida H, et al. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin ( BOMP )chemotherapy followed by radiotherapy versus radiotherapy alone in stage mb and lVa squamous cellcarcinoma of the cervix. Anticancer Res.2003.23:2885-2890. 被引量：1
6Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer,2002,38:270-278. 被引量：1
7Sardi JE,Giaroli A,Sananes C ,et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ⅰb squamous carcinoma of the cervix: the final results. Gynecol Oncol,1997,67:61-69. 被引量：1
8Duenas-Gonzalez A, Rivera L, Mota A. The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma. Arch Med Res ,2002,33:201-202. 被引量：1
9Duenas-Gonzalez A, Lopez-graniel C, Gonzalez-Enciso A, et al. Aphase Ⅱ study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol,2003,14 : 1278-1284. 被引量：1
10Benedet J1, Hacker NF, Ngan HYS, et al. Staging classifications and clinical practice guidelines of gynaecologic cancer, http://www. figo. org/content/PDF/staging-booklet, pdf. 被引量：1
2Kumar JV, Doval DC, Rao R, et al. A retrospective study of patiens with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy fol- lowed by radical surgery[J]. Int J Gynecol cancer, 2009,19(3) :417-422. 被引量：1
3Gatcliffe TA, Tewari KS, Shah A, et al. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally ad- vanced cervical cancer [ J ]. Gynecol oncol, 2009, 112 (1) :85-89. 被引量：1
4Sardi JE,Boixadera MA,Sardi JJ. Neoadjuvant chemother- apy in cervical cancer new trend[J]. Curt Opin Obstet Gynecol, 2005,17(1 ) : 43-47. 被引量：1
5Park D C,Kim J H,Lew YO,et al. Phase IItrial of neo- adjuvant paclitaxel and cisplatin in uterine cervical cancer[J ]. Gynecol Oncol,2004,92 (1) :59-63. 被引量：1
6Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para - aortic irradiation for high - risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90- 01[J ]. Clin Oncol,2004,22:872-880. 被引量：1
7Temkin SM,Yamada SD,Fleming GF. A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and / or recurrent gynecologic malignan- cies[J]. Gyneeol Oncol,2010,117(3):473-476. 被引量：1
